Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
FGWOKLCRQJXPPQ
|
6.4 | Ki | 14 | — | |
FSWFKKQQSQHIRZ
|
6.4 | Ki | 10 | — | |
GCZJQTRRJPRFIP
|
6.4 | Ki | 10 | — | |
GDYZFFBMSBDTAA
|
6.4 | Ki | 60 | — | |
HCJQIBXTZXVZLX
|
6.4 | IC50 | 2 | — | |
HIUHVDROHDSKTC
|
6.4 | Ki | 20 | — | |
JMQCXZBXWOIDIO
|
6.4 | Ki | 9 | — | |
LVXRFLDTIWZWSH
|
6.4 | IC50 | 2 | — | |
MBRVCJRFWYHVHE
|
6.4 | Ki | 9 | — | |
MCBPNFWHHNJTGN
|
6.4 | Ki | 3 | — | |
MJLKHAZEWYICMC
|
6.4 | Ki | 4 | — | |
MVWNPTRDUDXOPY
|
6.4 | IC50 | 5 | — | |
ONSQVIFJAFIKFZ
|
6.4 | Ki | 6 | — | |
PNAPQQCRNHMIER
|
6.4 | Ki | 12 | — | |
QBKUOOQFSVMDPB
|
6.4 | Ki | 31 | — | |
QVNZKVACBBTKSL
|
6.4 | Ki | 38 | — | |
RFBPWKMQWSIPEO
|
6.4 | Ki | 28 | — | |
RYYNGWLOYLRZLK
|
6.4 | Ki | 104 | — | |
SDTHQOXRWZXTJF
|
6.4 | Ki | 16 | — | |
UHSGKZKFUUFRPH
|
6.4 | IC50 | 4 | — | |
UNPCCYFJMCHROL
|
6.4 | IC50 | 2 | — | |
VFRCYLLWYAKOPH
|
6.4 | IC50 | 2 | — | |
VUCDRXKGXNTDKO
|
6.4 | IC50 | 2 | — | |
WDARYLSSWBWVCU
|
6.4 | Ki | 49 | — | |
WICLISNBDMGFST
|
6.4 | Ki | 10 | — | |
WMFVCLKZYKMDNK
|
6.4 | IC50 | 8 | — | |
WQEJLZRJDSKLCZ
|
6.4 | Ki | 5 | — | |
WUTVMXLIGHTZJC
|
6.4 | Ki | 5 | Yes | |
XEFKLIBFQSPJFO
|
6.4 | IC50 | 3 | — | |
XUGXUDSTKPTWNB
|
6.4 | Ki | 10 | — | |
YYPKOMNJRZRWIC
|
6.4 | Ki | 26 | — | |
ZBYGBITZFKOQTA
|
6.4 | Ki | 18 | — | |
ZGDYBJXDIXVTLV
|
6.4 | Ki | 54 | — | |
DFOQUEDJAQZZIV
|
6.4 | IC50 | 2 | — | |
PGPHHJBZEGSUNE
|
6.4 | IC50 | 3 | — | |
ROQWMUVYMUOSQS
|
6.4 | IC50 | 2 | — | |
UOPHVMRUNRZBPW
|
6.4 | IC50 | 2 | — | |
ZFJLHOJPSZZLSS
|
6.4 | IC50 | 2 | — | |
FWLMVFUGMHIOAA
|
6.4 | IC50 | 26 | — | |
OPIMPFVNTDPVQW
|
6.4 | IC50 | 2 | — | |
PHEXTCXTBBPBOL
|
6.4 | IC50 | 2 | — | |
UAILDZHGMNDSLW
|
6.4 | IC50 | 2 | — | |
AFBWGXIHPVUWLP
|
6.4 | IC50 | 2 | — | |
AKFVRSQELXTCFW
|
6.4 | IC50 | 2 | — | |
BULHRWBHKAVJMT
|
6.4 | IC50 | 8 | — | |
CMJCXYNUCSMDBY
|
6.4 | Kd | 15 | — | |
WLFQODQSEBJMDH
|
6.4 | IC50 | 2 | — | |
YJWFRUYKFYDTSQ
|
6.4 | IC50 | 2 | — | |
WYYSOGMUPDEQEM
|
6.4 | IC50 | 2 | — | |
BIIVYFLTOXDAOV
|
6.3 | IC50 | 12 | Yes |